Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Targeted binding agents directed to PDGFR-alpha and uses thereof

Targeted binding agents directed to PDGFR-alpha and uses thereof

US Patent 7754859 · Granted Jul 13, 2010

Estimated economic value: $8,681,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

MAGEB2 binding constructs2025
Nucleic acid molecules encoding binding proteins for gastric inhibitory peptide 2025
Human antigen binding proteins that bind β-klotho, FGF receptors and complexes t2024
Interleukin-2 muteins for the expansion of T-regulatory cells2024
ST2 antigen binding proteins2024
HNF4a saRNA compositions and methods of use2024
TIGIT and CD112R blockade2024
Interleukin-21 mutein/ anti-PD-1 antibody conjugates2023
Anti-PD-1 antibodies and methods of treatment2022
Targeted binding agents against B7-H12022
Targeted binding agents against B7-H12022
Antibodies directed to the deletion mutants of epidermal growth factor receptor 2022